Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Radiofrequency Ablation to Treat Hepatic Neoplasms

NCT00019604 is registered in ClinicalTrials.gov with National Institutes of Health Clinical Center (CC) as lead sponsor.

NCT NCT00019604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00019604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Radiofrequency Ablation to Treat Hepatic Neoplasms
Lead sponsor
National Institutes of Health Clinical Center (CC)
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 1998
Completion date
January 31, 2009
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer, metastatic cancer, unspecified adult solid tumor, protocol specific